Kinetic degradation study for the first licensed anti‐influenza polymerase inhibitor, baloxavir marboxil, using high‐performance liquid chromatography‐mass spectrometry-Reference-Cited by-同舟云学术

Kinetic degradation study for the first licensed anti‐influenza polymerase inhibitor, baloxavir marboxil, using high‐performance liquid chromatography‐mass spectrometry

Published:2022-05-20 Issue:14 Volume:45 Page:2488-2497
ISSN:1615-9306
Container-title:Journal of Separation Science
language:en
Short-container-title:J of Separation Science

Author:

Hafez Hani M.¹^ORCID,Abdel‐Halim Mohammad²^ORCID,Hemdan Ahmed³^ORCID,Hammam Mennatallah A.²⁴

Affiliation:

1. Department of Pharmacy Pharmaceutical Chemistry Lecturer, Al‐Esraa University College Baghdad Iraq

2. Department of Pharmaceutical Chemistry Faculty of Pharmacy and Biotechnology, German University in Cairo Cairo Egypt

3. Department of Pharmaceutical Analytical Chemistry Faculty of Pharmacy, Ahram Canadian University 6th of October City Egypt

4. Department of Pharmaceutical Analysis School of Life and Medical Sciences New Administrative Capital University of Hertfordshire hosted by Global Academic Foundation Cairo Egypt

Publisher

Wiley

Subject

Filtration and Separation,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jssc.202200020

Reference19 articles.

1. BranswellH.A flu drug ‐ shown to reduce the duration of symptoms ‐ could upend treatment in U.S.2018.https://www.statnews.com/2018/06/27/flu‐drug‐single‐pill/Accessed February 4 2021

2. Population Pharmacokinetic and Exposure-Response Analyses of Baloxavir Marboxil in Adults and Adolescents Including Patients With Influenza

3. Introducing the new anti-influenza drug, baloxavir marboxil

4. Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial

5. Detection and quantification of Covid-19 antiviral drugs in biological fluids and tissues

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous quantification of baloxavir marboxil and its active metabolite in human plasma using UHPLC-MS/MS: Application to a human pharmacokinetic study with different anticoagulants;Journal of Pharmaceutical and Biomedical Analysis;2024-10

2. Determination of baloxavir marboxil in pharmaceutical preparations and spiked human plasma using its quenching action on acetoxymercuric fluorescein reagent: Assessment of greenness and whiteness;Heliyon;2024-06

3. Stability‐indicating method development and validation for quantitative estimation of organic impurities of the antidiabetic drug glipizide in drug substance and pharmaceutical dosage form using HPLC;Biomedical Chromatography;2023-08-27

4. Ecofriendly stability-indicating UHPLC-PDA method for determination of the new influenza antiviral prodrug Baloxavir Marboxil; application to degradation kinetic studies and structure elucidation of the major degradation products using LC-MS;Sustainable Chemistry and Pharmacy;2023-06

5. LC-MS/MS-based metabolite quantitation of the antiviral prodrug baloxavir marboxil, a new therapy for acute uncomplicated influenza, in human plasma: Application to a human pharmacokinetic study;Journal of Pharmaceutical and Biomedical Analysis;2023-01